金地集團(600383.SH):子公司擬以3000萬元認購私募基金份額 其主投生物醫藥、醫療器械、診斷及其他醫療健康企業
格隆匯9月17日丨金地集團(600383.SH)公佈,2021年9月16日,公司子公司南京威新房地產開發有限公司(“南京威新”)簽署了《蘇州博遠厚誠二期股權投資合夥企業(有限合夥)合夥協議》,南京威新作為有限合夥人在標的基金中認繳出資人民幣3000萬元。
標的基金主要針對在中國區域內設立的或主要運營在中國境內的醫藥、生物科技、醫療服務、醫療器械、設備、診斷、醫療 IT、動物保健及其他醫療健康相關領域的企業進行股權投資或以股權投資為目的的可轉債投資。
標的基金主要投資領域為生物醫藥、醫療器械、診斷及其他醫療健康企業,此次投資有利於公司進一步拓展與醫療健康領域企業的潛在合作機會,探索通過醫療康養與地產結合的形式提升公司自身品牌價值,支持公司主營業務發展。公司在保證日常經營所需資金的前提下,使用自有資金認購標的基金,有利於進一步提高公司資金使用效率,此次投資不會影響公司主營業務的正常開展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.